Pulsus, Canadian Journal of Gastroenterology, 3(27), p. 137-147
DOI: 10.1155/2013/924640
Full text: Download
BACKGROUND: The prevalence of chronic hepatitis B (CHB) infection among immigrants to North America ranges from 2% to 15%, 40% of whom develop advanced liver disease. Screening for hepatitis B surface antigen is not recommended for immigrants.